<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.fourmentinguilbert.org/events/aggregator/previous/RSS">
  <title>Past Events</title>
  <link>http://www.fourmentinguilbert.org</link>
  
  <description>
    
       Events which have already happened.
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2009-12-28T16:17:26Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.fourmentinguilbert.org/logo.png"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/events/brevetabilite-du-vivant-le-modele-economique-de-lindustrie-des-biotechnologies-est-il-en-danger"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/events/allegations-sante-dans-lalimentaire-quelles-solutions-pour-reussir-lexamen-reglementaire-peut-on-faire-reference-aux-etudes-cliniques-sur-les-medicaments"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/events/creer-acquerir-developper-en-agro-alimentaire.-comment-financer"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/postings/foundation-week"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/postings/modelling-complex-biological-systems-in-the-context-of-genomics"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/events/soiree-hec-sante-et-x-biotech"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/postings/interfacing-systems-biology-and-synthetic-biology"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/events/de-la-recherche-a-la-creation-dentreprise-lexemple-des-agro-bio-technologies-1"/>
        
        
            <rdf:li rdf:resource="http://www.fourmentinguilbert.org/postings/synthetic-biology"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.fourmentinguilbert.org/events/brevetabilite-du-vivant-le-modele-economique-de-lindustrie-des-biotechnologies-est-il-en-danger">        <title>Brevetabilité du vivant: le modèle économique de l'industrie des biotechnologies est-il en danger ?</title>        <link>http://www.fourmentinguilbert.org/events/brevetabilite-du-vivant-le-modele-economique-de-lindustrie-des-biotechnologies-est-il-en-danger</link>        <description>Le modèle économique des biotechnologies fondé sur les brevets risque d'être remis en cause suite à l'invalidation de brevets sur des gènes liés aux cancers du sein et de l'ovaire par un tribunal américain.  Yann Ménière et le Cabinet Regimbea sont invités à nous éclairer sur cette problèmatique.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>nathalie</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-05-26T10:09:47Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/events/allegations-sante-dans-lalimentaire-quelles-solutions-pour-reussir-lexamen-reglementaire-peut-on-faire-reference-aux-etudes-cliniques-sur-les-medicaments">        <title>Allégations santé dans l'alimentaire </title>        <link>http://www.fourmentinguilbert.org/events/allegations-sante-dans-lalimentaire-quelles-solutions-pour-reussir-lexamen-reglementaire-peut-on-faire-reference-aux-etudes-cliniques-sur-les-medicaments</link>        <description>Les allégations santé représentent de réelles opportunités pour les industriels de l'agroalimentaire et les fabricants d'ingrédients fonctionnels issus des biotechnologies.  Toutefois, le contexte réglementaire se durcit et les modèles scientifiques de recherche clinique, bien souvent issus de l'industrie pharmaceutique, montrent certaines limites technico économiques. 
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>nathalie</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-05-26T10:33:24Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/events/creer-acquerir-developper-en-agro-alimentaire.-comment-financer">        <title>Créer, acquérir, développer en agro-alimentaire. Comment financer ?</title>        <link>http://www.fourmentinguilbert.org/events/creer-acquerir-developper-en-agro-alimentaire.-comment-financer</link>        <description>Partager les expériences des entreprises agro-alimentaires pour faire face aux problématiques de leur financement au cours de leur vie et de leurs activités.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>nathalie</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-05-26T09:59:16Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/postings/foundation-week">        <title>Foundation Week </title>        <link>http://www.fourmentinguilbert.org/postings/foundation-week</link>        <description>For the first time ever, the EFC is holding a Foundation Week, an event that includes Open Days for the public and other stakeholders in the run-up to the EFC’s Annual General Assembly (AGA) and Conference.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin2</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-01-20T14:50:27Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/postings/modelling-complex-biological-systems-in-the-context-of-genomics">        <title>Modelling Complex Biological Systems in the Context of Genomics </title>        <link>http://www.fourmentinguilbert.org/postings/modelling-complex-biological-systems-in-the-context-of-genomics</link>        <description>The post-genomic era of biology is characterised by a deluge of molecular data about the cell. This `new' biology has its own vocabulary of genome, transcriptome, proteome and even metabolome, interactome and lipidome. The challenge is to make sense out of this information by coming up with a new integrated picture of the cell which takes into account that it is simultaneously an autocatalytic set, a tensegrity structure, a network or a set of networks with particular connectivities and feedback characteristics, a set of codes and decoding devices, a self-organising system ... and so on. Taking on this challenge therefore also requires the introduction of concepts unfamiliar to biologists and the development of new ones, the formulation of new hypotheses and their testing via simulations or wet experiments. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin2</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-02-21T10:21:20Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/events/soiree-hec-sante-et-x-biotech">        <title>Soirée HEC Santé et X-Biotech</title>        <link>http://www.fourmentinguilbert.org/events/soiree-hec-sante-et-x-biotech</link>        <description>OPEN INNOVATION – R&amp;D COLLABORATIVE : QUEL IMPACT SUR LES INDUSTRIES DE SANTE ?</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin2</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-03-16T17:12:31Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/postings/interfacing-systems-biology-and-synthetic-biology">        <title>Interfacing Systems Biology and Synthetic Biology</title>        <link>http://www.fourmentinguilbert.org/postings/interfacing-systems-biology-and-synthetic-biology</link>        <description>The symposium is organized by the National Committee for Microbiology, as part of the Royal Academies for Science and the Arts of Belgium, further supported by BIOSCENTER</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin2</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-02-21T10:14:04Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/events/de-la-recherche-a-la-creation-dentreprise-lexemple-des-agro-bio-technologies-1">        <title>De la recherche à la création d'entreprise, l'exemple des agro-bio-technologies</title>        <link>http://www.fourmentinguilbert.org/events/de-la-recherche-a-la-creation-dentreprise-lexemple-des-agro-bio-technologies-1</link>        <description>Cette conférence est organisée par Agro Entrepreneurs et le Club UniAgro et sera animée par Jean-Paul Hébrard, rédacteur en chef d'Agriculture et Nouvelles Technologies</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>nathalie</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-03-02T11:10:09Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.fourmentinguilbert.org/postings/synthetic-biology">        <title>Synthetic biology </title>        <link>http://www.fourmentinguilbert.org/postings/synthetic-biology</link>        <description>Véronique Stoven (Mines ParisTech) and Antoine Danchin (Université de Hong-Kong et AMAbiotics) will speak about synthetic biology</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin2</dc:creator>        <dc:rights></dc:rights>                <dc:date>2010-01-03T05:49:50Z</dc:date>        <dc:type>Event</dc:type>    </item>




</rdf:RDF>
